Swim training restores glucagon-like peptide-1 insulinotropic action in pancreatic islets from monosodium glutamate-obese rats

Acta Physiologica

Volumn 209, Issue 1, 2013, Pages 34-44

  Svidnicki, P V ^a   de Carvalho Leite, N ^a   Venturelli, A C ^a   Camargo, R L ^b   Vicari, M R ^a   de Almeida, M C ^a   Artoni, R F ^a   Nogaroto, V ^a   Grassiolli, S ^a  

^a STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Exercise; Insulin secretion; Obesity

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLUTAMATE SODIUM; INSULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; EXERCISE; GENE EXPRESSION; GLUCOSE INTAKE; HORMONE RELEASE; INSULIN RELEASE; NEWBORN; NONHUMAN; OBESITY; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT; SWIMMING; TRAINING; ANIMAL; DRUG EFFECTS; METABOLISM; PANCREAS ISLET; PHYSIOLOGY; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; OBESITY; PHYSICAL CONDITIONING, ANIMAL; RATS, WISTAR; SODIUM GLUTAMATE; SWIMMING;

EID: 84881547116     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12128     Document Type: Article

References (51)

1. Ahrén, B. 2009. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8, 369-385.
2. Alponti, R.F. & Silveira, P.F. 2010. Neutral aminopeptidase and dipeptidyl peptidase IV activities in plasma of monosodium glutamate obese and food-deprived rats. Obesity (Silver Spring) 18, 1312-1317.
3. Alponti, R.F., Frezzatti, R., Barone, J.M., Alegre, V.S. & Silveira, P.F. 2011. Dipeptidyl peptidase IV in the hypothalamus and hippocampus of monosodium glutamate obese and food-deprived rats. Metabolism 60, 234-242.
4. Andreazzi, A.E., Scomparin, D.X., Mesquita, F.P., Balbo, S.L., Gravena, C., De Oliveira, J.C., Rinaldi, W., Garcia, R.M., Grassiolli, S. & Mathias, P.C. 2009. Swimming exercise at weaning improves glycaemic control and inhibits the onset of monosodium L-glutamate-obesity in mice. J Endocrinol 201, 351-359.
5. Balbo, S.L., Grassiolli, S., Ribeiro, R.A., Bonfleur, M.L., Gravena, C., Brito, M.D.N., Andreazzi, A.E., Mathias, P.C. & Torrezan, R. 2007. Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat. Endocrine 31, 142-148.
6. Bernardis, L.L. & Patterson, B.D. 1968. Correlation between 'Lee index' and carcass fat content in weanling and adult female rats with hypothalamic lesions. J Endocrinol 40, 527-528.
7. Blouet, C. & Schwartz, G.J. 2010. Hypothalamic nutrient sensing in the control of energy homeostasis. Behav Brain Res 209, 1-12.
8. Boss, O., Samec, S., Desplanches, D., Mayet, M.H., Seydoux, J., Muzzin, P. & Giacobino, J.P. 1998. Effect of endurance training on mRNA expression of uncoupling proteins 1, 2, and 3 in the rat. FASEB J 12, 335-339.
9. Broom, D.R., Batterham, R.L., King, J.A. & Stensel, D.J. 2009. Influence of resistance and aerobic exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males. Am J Physiol Regul Integr Comp Physiol 296, 29-35.
10. Burmeister, M.A., Bracy, D.P., James, F.D., Holt, R.M., Ayala, J., King, E.M., Wasserman, D.H., Drucker, D.J. & Ayala, J.E. 2012. Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor. J Physiol 590, 5245-5255.
11. Calegari, V.C., Zoppi, C.C., Rezende, L.F., Silveira, L.R., Carneiro, E.M. & Boschero, A.C. 2011. Endurance training activates AMP-activated protein kinase, increases expression of uncoupling protein 2 and reduces insulin secretion from rat pancreatic islets. J Endocrinol 208, 257-264.
12. Carvalho-Leite, N., Ferreira, T.R., Rickli, S., Borck, P.C., Mathias, P.C.F., Emilio, H.R.O. & Grassiolli, S. 2013. Glycolytic and Mitochondrial Metabolism in Pancreatic Islets from MSG-Treated Obese Rats Subjected to Swimming Training. Cell Physiol Biochem 31, 242-256.
13. Chen, Y., Li, Z.Y., Yang, Y. & Zhang, H.J. 2012. Uncoupling protein 2 regulates glucagon-like peptide-1 secretion in L-cells. World J Gastroenterol 18, 3451-3457.
14. Dawson, R., Wallace, D.R. & Gabriel, S.M. 1989. A pharmacological analysis of food intake regulation in rats treated neonatally with Monosodium L-Glutamate (MSG). Pharmacol Biochem Behav 32, 391-398.
15. Dela, F., Linstow, M.E.V., Mikines, K.J. & Galbo, H. 2004. Physical training may enhance B-cell function in type 2 diabetes. Am J Physiol Endocrinol Metab 287, 1024-1031.
16. Després, J.P. & Lemieux, I. 2006. Abdominal obesity and metabolic syndrome. Nature 444, 881-887.
17. Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A.M., Baggio, L.L., Meier, D.T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y.D. et al. 2011. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17, 1481-1489.
18. Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U. & Perfetti, R. 2002. Glucagon-like Peptide-1 promotes islet cell growth and inhibits apoptosis in zucker diabetic rats. Endocrinology 143, 4397-4408.
19. Gobatto, C.A., Mello, M.A.R., Sibuya, C.Y., Azevedo, J.R.M., Santos, L.A. & Kokubun, E. 2001. Maximal lactate steady state in rats submitted to swimming exercise. Comp Biochem Phys A 130, 21-27.
20. Grassiolli, S., Gravena, C. & Mathias, P.C.F. 2007. Muscarinic M2 receptor is active on pancreatic islets from hypothalamic obese rat. Euro J Pharmacol 556, 223-228.
21. Hansen, A.M.K., Bodvarsdottir, T.B., Nordestgaard, D.N.E., Heller, R.S., Gotfredsen, C.F., Maedler, K., Fels, J.J., Holst, J.J. & Karlsen, A.E. 2011. Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomysobesus-an adaptive response to hyperglycaemia? Diabetologia 54, 1379-1387.
22. Hirata, A.E., Andrade, I.S., Vaskevicius, P. & Dolnikoff, M.S. 1997. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res 30, 671-674.
23. Holst, J.J. 2007. The physiology of glucagon-like Peptide 1. Physiol Rev 87, 1409-1439.
24. Holst, J.J. & Gromada, J. 2004. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab 287, 199-206.
25. Kahn, S.E., Hull, R.L. & Utzschneider, K.M. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846.
26. Király, M.A., Bates, E.H., Yue, J.T.Y., Goche-Montes, D., Fediuc, S., Park, E., Matthews, S.G., Vranic, M. & Riddell, M.C. 2007. Attenuation of type 2 diabetes mellitus in the male Zucker diabetic fatty rat: the effects of stress and non-volitional exercise. Metabolism 56, 732-744.
27. Király, M.A., Bates, E.H., Kaniuk, N.A., Yue, J.T.Y., Brumell, J.H., Matthews, S.G., Riddell, M.C. & Vranic, M. 2008. Swim training prevents hyperglycemia in ZDF rats: mechanism involved in the partial maintenance of B-cell function. Am J Physiol Endocrinol Metab 294, 271-283.
28. Kjems, L.L., Holst, J.J., Volund, A. & Madsbad, S. 2003. The influence of GLP-1 on glucose stimulated Insulin Secretion Effects on B-Cell Sensitivity in type 2 and Nondiabetic Subjects. Diabetes 52, 380-386.
29. Knop, F.K. 2009. Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling? Diabetologia 52, 2270-2276.
30. Kubota, A., Nakagawa, Y. & Igarashi, Y. 1994. Studies of gene expression in liver of insulin-like growth factor (IGF)-I, IGF binding protein-3 and growth hormone (GH) receptor/GH binding protein in rats treated neonatally with monosodium glutamate. Horm Metab Res 26, 497-503.
31. Lacy, P.E. & Kostianovsky, M. 1967. Method of the isolation of intact islets of Langerhans from rat pancreas. Diabetes 16, 35.
32. Larsen, P.J., Fledelius, C., Knudsen, L.B. & Tang-Christensen, M. 2001. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 50, 2530-2539.
33. Larson-Meyer, D.E., Palm, S., Bansal, A., Austin, K.J., Hart, A.M. & Alexander, B.M. 2012. Influence of running and walking on hormonal regulators of appetite in women. J Obesity 2012, 15.
34. Livak, K.J. & Schmittgen, T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
35. Maarbjerg, S.J., Sylow, L. & Richter, E.A. 2011. Current understanding of increased insulin sensitivity after exercise - emerging candidates. Acta Physiol (Oxf) 202, 323-335.
36. Martínez-Rodrígues, R. & Gil, A. 2012. Nutrient-mediated modulation of incretin gene expression: a systematic review. NutrHosp 27, 46-53.
37. Miguel, J.C., Abdel-Wahab, Y.H.A., Green, B.D., Mathias, P.C.F. & Flatt, P.R. 2003. Cooperative enhancement of insulinotropic action of GLP-1 by acetylcholine uncovers paradoxical inhibitory effect of beta cell muscarinic receptor activation on adenylatecyclase activity. Biochem Pharmacol 65, 283-292.
38. Mlinar, B., Marc, J., Janez, A. & Pfeifer, M. 2007. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 375, 20-35.
39. Morrison, J.F.B., Shehab, S., Sheen, R., Dhanasekaran, S., Shaffiullah, M. & Mensah-Brown, E. 2008. Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes. Exp Physiol 93, 213-222.
40. Murphy, K.G. & Bloom, S.R. 2006. Gut hormones and the regulation of energy homeostasis. Nature 444, 854-859.
41. Naslund, E., Gutniak, M., Skogar, S., Rossner, S. & Hellstrom, P.M. 1998. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr 68, 525-530.
42. Nauck, M.A., Holst, J.J. & Willms, B. 1997. Glucagon-like peptide 1 and its potential in the treatment of non-insulin-dependent diabetes mellitus. Horm Metab Res 29, 411-416.
43. Nauck, M.A., Vardarli, I., Deacon, C.F., Holst, J.J. & Meier, J.J. 2011. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 54, 10-18.
44. Person, P.B. & Henriksson, J. 2011. Good publication practise in physiology. Acta Physiol 203, 403-407.
45. Sagae, S.C., Grassiolli, S., Raineki, C., Balbo, S.L. & Da Silva, A.C.M. 2011. Sex differences in brain cholinergic activity in MSG-obese rats submitted to exercise. Can J Physiol Pharmacol 89, 845-853.
46. Scheurink, A.J., Steffens, A.B., Bouritius, H., Dreteler, G.H., Bruntink, R., Remie, R. & Zaagsma, J. 1989. Adrenal and sympathetic catecholamines in exercising rats. Am J Physiol 256, 155-160.
47. Scomparin, D.X., Gomes, R.M., Grassiolli, S., Rinaldi, W., Martins, A.G., De Oliveira, J.C., Gravena, C. & Mathias, P.C. 2009. Autonomic activity and glycaemic homeostasis are maintained by precocious and low intensity training exercises in MSG-programmed obese mice. Endocrine 36, 510-517.
48. Tahrani, A., Bailey, C.J., Del Prato, S. & Barnett, A.H. 2011. Management of type 2 diabetes: new and future developments in treatment. Lancet 378, 182-197.
49. Tang-Christensen, M., Vrang, N. & Larsen, P.J. 1998. Glucagon-like peptide 1 (7-36) amide's central inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes 47, 530-537.
50. Ueda, S., Yoshikawa, T., Katsura, Y., Usui, T., Nakao, H. & Fujimoto, S. 2009. Changes in gut hormone levels and negative energy balance during aerobic exercise in obese young males. J Endocrinol 201, 151-159.
51. Young, A.A., Gedulin, B.R., Bhavsar, S., Bodkin, N., Jodka, C., Hansen, B. & Denaro, M. 1999. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies on obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes 48, 1026-1034.